From September to around early January 2021 will be a big year for Immutep one way or another...
Firstly, data presented at ESMO will be critical ! It needs to be favourable ! Then our regular analyst can start reporting some positive news which should see a rerating of the stock price so it's not for the faint-hearted at the moment.
MV interview on 180 markets was interesting. He commented that "data from BMS phase 3 trail using the Lag- 3 drug will be release by the end of the year or beginning of next. If favourable, immutep being a world leader in the LAG-3 space should positively influence our development "
I think thats was an important statement which i never considered before.
Ann: Appendix 4E & 2020 Full Year Statutory Accounts, page-33
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.040(11.0%) |
Mkt cap ! $588.3M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 40.5¢ | 36.8¢ | $1.822M | 4.681M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19739 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 45420 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |